NEJM Interview: Dr. Aaron Kesselheim on the challenges of bringing follow-on biologic drugs to the market.
Jun 17, 2015
12:27
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Aaron Kesselheim is an associate professor of medicine at Harvard Medical School and a member of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women's Hospital. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. A. Sarpatwari, J. Avorn, and A.S. Kesselheim. Progress and Hurdles for Follow-on Biologics. N Engl J Med 2015;372:2380-2.
NEJM Interviews